Toxicology Letters

Article	Citations
S05-03 The development of a human liver-based In Vitro test battery to detect liver steatotic potential of chemicals from various applicability domains	55
P02-46 Cultivation conditions in microfluidic environments: insights from 2D and 3D cell culture models	43
P01-39 Mitochondrial toxicity screening to support the R&D crop protection pipeline	37
P07-09 Spatio-temporal multi-omics analysis of lung tissue and matched biofluids identifies circulatory safety biomarkers for monitoring inhaled drug induced lung injury	34
P02-47 A rat in vitro 3D airway model for translational toxicology	31
P09-10 The synthetic cannabinoid ADB-FUBINACA disrupts mitochondrial biogenesis of NG108-15 neuroblastoma cells during neuronal differentiation at human-relevant concentrations	30
S20-04 Generic pharmacokinetic models for mother-to-offspring transfer of environmental chemicals	30
P12-13 Role of endoplasmic reticulum stress in sunitinib-induced hepatotoxicity	30
P02-26 Optimized iPSC-derived hepatocytes offer a novel liver cell model for in vitro predictive toxicity and drug efficacy studies	27
P17-07 Prenatal exposure to acrylamide and metabolic status at 20 years of age: a prospective biomarker-based cohort study from Denmark	27
P08-03 Comprehensive digital documentation and computer-assisted evaluation of the skeleton of Alizarin Red and Alcian Bluestained rat foetuses	27
P21-54 Searching for links in binding patterns among androgen and progesterone receptor ligands	26
P07-05 Miniaturization of haematology sampling in rodents on toxicology studies	26
The toxicology of inhaled nanomaterials and examples of risk assessment and regulation	25
P19-50 In-chemico reactivity methods based on molecular initiating event of skin sensitization: refinements and possible application to cosmetic formulations	25
P07-18 Acute phase proteins in Göttingen minipigs: comparison between haptoglobin, Pig-MAPP and CRP in the context of a vaccine study	25
P14-06 The cytotoxicity of bortezomib in AC16 cardiac cells and possible therapeutic options involving Nrf2	24
P02-22 Establishment of a microfluidic neurotoxicity screening model using human iPSCs-differentiated motor neurons within the New Approach Methodologies for chemical safety developed for Precision To	22
P08-10 Advancing the use of New Approach Methodologies for assessing teratogenicity using a tiered approach: metabolism consideration to improve the human relevance	22
P13-36 In silico analysis of positive and negative effects of isothiocyanates in breast cancer	21
P20-27 Zinc suphide – considerations and challenges for acute inhalation toxicity testing and classification under REACH	21
P19-03 Integration of transcriptomics data for ED assessments using an Adverse Outcome Pathway Network approach	21
P06-04 Advancing bladder cancer detection: unveiling a novel urinary biomarker panel through metabolomics	21
Toxicokinetic relationship between the adducts in globin and their cleavage products in the urine: Implications for human biomonitoring	20
LP-10 Comparative analysis of occupational exposure limits (OELs) for inhibiting RNA therapeutics	20

circ_0000554 promotes macrophage M2 polarization mediated by glycolytic reprogramming and aggravates COPD injury	20
P33-06 Disruption of the plasma membrane organization and neuroinflammation can be triggered by toxic organophosphorus compounds	19
Non-alcoholic fatty liver disease changes the expression and activity of hepatic drug-metabolizing enzymes and transporters in rats	19
S04-03 Sponsor Perspectives on Implementing WOE Approaches	19
S23-02 Assessment and modelling of metabolites: the conazole case study	19
P22-24 Polystyrene nanoplastics induced cognitive impairment through dysregulation of autophagy and synaptic plasticity in rats	19
Exosomal miR-196b secreted from bronchial epithelial cells chronically exposed to low-dose PM2.5 promotes invasiveness of adjacent and lung cancer cells	19
S13-02 NAMs to investigate chemical-induced immunotoxicity: the cases of PFAS and BPA analogs	18
P29-11 A delayed activation of p38 MAPK in dendritic cells distinguishes respiratory from skin sensitizers	17
P09-11 The disruption of the human astrocytic cell cycle by hexavalent chromium	17
OS01-08 Activity-based characterization of New Psychoactive Substances (NPS): a forgotten technology with new forensic applications	17
P09-33 Oxidative Potential of Traffic-Derived Ultrafine Particles and Their Impact on Olfactory Mucosa Cells in Alzheimer's Disease	17
Are electric vehicles actually bad for the environment?	17
S24-02 Studying and comparing the role of time in in vitroand in vivotoxicity tests	17
S02-01 Probabilistic Risk Assessment in Practice	17
P28-20 Challenges and Best Practices in Conducting Multigenerational Studies: A CRO Perspective	17
P09-14 Health Impact of PM2.5 on Pregnant women and Children: Systematic Review	17
P07-07 Investigation of the Endocrine Disrupting Effects of Lilial	17
P14-07 Outcome of the re-assessment of the risks to public health related to the genotoxicity of styrene present in plastic food contact materials	16
S27-03 The microbiome modifies neurobehavior in zebrafish exposed to Aryl Hydrocarbon Receptor (AHR) modulators	16
S08-02 Current and emerging concepts of cardiotoxicity: applicability inrisk assessment for regulatory purposes	16
P24-11 Waiving of the dog studies in the regulatory process of agrochemicals approval	16
P12-26 Effect of ketogenic diet on the metabolism of ozanimod in mice	16
P31-33 Classification based risk assessment in the safety evaluation of Extractables & Leachables	16
CEC04-05 Feasability of quality criteria and tentative assessment tools to align with artificial intelligence	16
P23-11 RVG-modified sEVs selectively delivers BDNF to brain, promotes neurogenesis and mitigates Parkinson-like symptoms	16
P23-08 Importance of Buccal Micronucleus Assay in the Biomonitoring of DNA Damage in Paint Workers	16
P23-14 Heavy Metals: Toxicity and Renal Damage	16
The MIR100HG/miR-29a-3p/Tab1 axis modulates TGF-β1-induced fibrotic changes in type II alveolar epithelial cells BLM-caused lung fibrogenesis in mice	15
Comparative effects of e-cigarette and conventional cigarette smoke on in vitro bronchial epithelial cell responses	15
The mouse Anxa6/miR-9-5p/Anxa2 axis modulates TGF-β1-induced mouse hepatic stellate cell (mHSC) activation and CCl4-caused liver fibrosis	15
A battery of assays for chasing ricin and its activity	15
Evaluating applicability domain of acute toxicity QSAR models for military and industrial chemical risk assessment	15
The harmful acute effects of clomipramine in the rat liver: Impairments in mitochondrial bioenergetics	15
Inhibition of placental 11β-HSD2 expression through cAMP/PKA signaling pathway induces intrauterine growth retardation	15
P11-01 BPS and BPF by acting as mitochondrial disrupting chemicals cause changes in energy metabolism in human ovarian granulosa cells	15
S13-04 Skin sensitization potency assessment: Make full use of NAM data to conduct quantitative risk assessment	15
Enhancement of cigarette smoke extract-induced goblet cell metaplasia and hyperplasia exerted through IL-13 receptor α1 expression	14
P13-07: High-dimensional profiling of immune response to vaccines using bio-stabilized and injectable natural human skin	14
Lysosomal membrane permeabilization mediated apoptosis involve in perphenazine-induced hepatotoxicity in vitro and in vivo	14
P09-46: Preliminary results of the second National Human Biomonitoring program in Slovenia: bisphenols, parabens, PFAS, glyphosate and trace elements in children and adolescents	14
P17-36: Ti-alloy (TiAl6Nb7) metal powder toxicity in human embryonic kidney (HEK-293T) cell line	14
LP-17: Evaluation of Genistein as a Mitochondrial Modulator and its Effects on Sperm Motility	14
P22-35: Mapping of DNT NAMs’ signaling pathways in human physiology and disease for regulatory application	14
P08-21 Lack of genotoxicity of Rhamnus Purshiana, Sennae Fructus, and Rhamnus Frangula in a micronucleus assay in vitro (OECD 787)	13
P10-09: Toxicological aspects of the Horizon EDIAQI project	13
S09-03: NAMs in DART testing of pharmaceuticals under ICHS5(R3)	13
P23-05: Urinary monohydroxyl-polycyclic aromatic hydrocarbons and metals in firefighters with active participation in controlled structure fires	13
P19-05: Comparison of in vitro and in vivo study results for classification of plant protection products	13
P09-34: Unraveling hormonal dependencies and associated species-specificities of neurodevelopmental key events to improve EDC risk assessment	13

P25-13: Polo-like kinase 4 (PLK4) Safety Review – distilling the risks with a rapid augmented intelligence approach	13
P22-02: The Renal Proximal Tubule TXG-MAPr: Safety Assessment Based On Quantitative Gene Network Analysis	13
Evidence for adduction of biologic amines with reactive metabolite of 8-epidiosbulbin E acetate in vitro and in vivo	13
S12A-03: Occupational exposure to copper in dust: Chemical characterization and impact on regulation	13
P22-31: Training the next-generation toxicologists	13
KL02 | EUROTOX Lecture Award	13
OS03-10: Predictive Modeling of Deltamethrin Exposure in Fetal Brain Tissue: Implications for Human Health Risk Assessment	13
P17-26 Assessment of anabolic steroids impact on 5β-reductase by virtual screening and in vitro approaches	12
P03-03 Autopsy findings and toxicological results in Khat-related fatalities in Jazan, Saudi Arabia	12
P08-18 Predicting non-genotoxic carcinogenic potential of agrochemicals: a mechanistic approach	12
P08-15 Assessing of in vitro genotoxicity testing strategy for T-2 mycotoxin	12
P13-07 Addition of physiologically relevant conditions has the potential to effect the toxicology of engineered nanomaterial hazards in an in vitro co-culture of the alveolar region of the lung	12
SOC-I-06 Differentially expressed microRNAs in human bronchial epithelial cells after exposure to nanofibrillar, microfibrillar or nanocrystalline cellulose	12
P19-07 Dermal occupational exposure assessment – comparison of selected modeling tools	12
LP-40: Non-clinical Safety profile of a new i.v. Formulation of Rifabutin (BV100) – an Opportunity for new Treatments	12
P19-08 New values of occupational exposure limits (OELs) of inhalation anesthetics: enflurane, isoflurane, sevoflurane and desflurane in Poland	11
P16-05 Influence of the new potential antidepressant SMe1EC2M3 treatment on neuronal outgrowth and arborization	11
S11-01: A regulatory perspective: hazard identification and potency classification	11
P05-06 Protective role of peroxiredoxin V against UVB-induced apoptosis of epidermal keratinocytes	11
P22-17 Acrylamide exposure estimates in the EuroMix biomonitoring study using a probabilistic approach	11
CEC07-03 Towards internal threshold of toxicological concern (iTTC): Implementation of Pharmacokinetics (PK) in the safety assessment	11
P03-21 Magic mushrooms and psilocybin: pharmacokinetics, pharmacodynamics, and clinical applications	11
S-29-02 Assessing the risk of mitochondrially active compounds in medicines development	11
P16-01 Silver nanoparticles suppressed retinoic acid-induced neuronal differentiation in SH-SY5Y cells	11
P14-04 Compartmental toxicokinetic model for urinary excretion of cleavage products resulting from adducts with globin	11
P21-17 Risk assessment of chemicals in the Dutch red meat production chain	11
Reviewers	11
P06-22 Reproductive and developmental toxicity testing of a complex UVCB: implications of current dose setting advice under REACH for generating meaningful study outcomes	11
P21-31 Criteria for selecting physiologically-based kinetic models for use in developing new models for data-poor analogues via a read-across approach	11
Copper exposure at a daily dose twice the recommended in diabetic rats induces oxidative stress, vascular dysfunction and perivascular adipose tissue inflammation in diabetic rats	10
PL04-01 Challenges and opportunities for regulatory toxicology under the chemicals strategy for sustainability	10
P22-16: Heated tobacco and e-vapour products induce lower biological activity compared to cigarettes using the ToxProfiler assay	10
P08-08 Toxicogenic effects of leaf extracts from an Andean medicinal plant	10
Skin penetration and decontamination efficacy following in vitro human skin exposure to sulfur mustard	10
Comparative toxicity of eleven bisphenol analogs in the nematode Caenorhabditis elegans	10
Effects of chlorpyrifos on transient receptor potential channels	10
P02-30 Generation and evaluation of a historical control database for the creation of assay acceptance criteria for a comparative in vitro hepatic enzyme assay	10
S-01-03 Integrating in vitro distribution kinetics analysis in IVIVE-PBK	10
P04-19 Selecting drug like structures using in silico tools	10
P17-27: Role of oxidative stress in microplastic polymethyl methacrylate (PMMA)-induced hepatotoxicity with HepG2/THP-1 co-culture model	10
A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure	10
Gentamicin administration leads to synaptic dysfunction in inner hair cells	10
A suitable silicosis mouse model was constructed by repeated inhalation of silica dust via nose	10
P01-62 Development of an in vitro model of dry nose	10
LP-46: Counterfeit drugs awareness among a Mexican sample: An underappreciated health risk	10
LP-27: Combination of air- and biomonitoring to control cadmium exposure at the workplace	10
S-17-02 Prioritization of contaminants for evaluation in food by WHO/FAO expert committees	10
S-03-02 Development of T2 MRI biomarker of neurotoxicity as a noninvasive quantitative approach	10
Individual and mixed effects of PFAS on osteoporosis: Insights from epidemiological and bioinformatic approaches	10
Cigarette smoke extract mediates cell premature senescence in chronic obstructive pulmonary disease patients by up-regulating USP7 to activate p300-p53/p21 pathway	10
P17-03 Toxic and essential metals in breast milk: Preliminary results from Bosnia and Herzegovina	9
P21-56 Shedding light on the epidermal alterations induced by blue light and heated tobacco products co-exposure: an in vitro study	9
S23-04 RapidTox: decision-based workflow environment to advance human health assessment	9
Endocrine disruptors and microplastics: facing complexity with connection	9
P23-11 Assessment of PAH exposure in trainee firefighters using a PAH CALUX bioassay	9
P26-02 Ensuring pharmaceutical packaging safety: an integrated approach for assessing extractable profiles and toxicological risk	9
CEC01-01 Introduction into the AOP framework: Integrating Theory and Practice in AOP Development	9
P25-07 Do co-formulants influence PPP genotoxicity? – a case study	9
P02-18 Using individual-centric model to detect immune-mediated idiosyncratic drug-induced liver injury at preclinical stage	9
P03-03 Quantitative in vitro to in vivo extrapolation (QIVIVE) for liver-induced thyroid toxicity risk assessment	9
P09-18 Comprehensive search for genes that vary across three developmental neurotoxicants	9
Title Page	9
P19-26 Moving towards a framework for in vitro risk assessment and determination of human relevance of rodent liver-mediated thyroid toxicity	9
S24-02 Biomarkers of neurodevelopmental effect can reduce uncertainty when assessing the risks of thyroid disrupting chemicals	9
CEC04-02 Comparison of outdoor and indoor air pollution on cardio-pulmonary health	9
OS02-03 Using a systems biology approach to construct adverse outcome pathway networks aligned with the FAIR principles	9
S02-04 Computational Toxicology in Drug Safety	9
P18-15 Determination of tramadol and its metabolite O-desmethyltramadol in blood and vitreous humor samples	9
P19-32 Advancing the application of New Approach Methodologies (NAMs) in systemic toxicity assessment of cosmetic ingredients: insights from cosmetics Europe long range science strategy (2016–2022) ca	9
S23-01 The ASPIS-initiated Safety Profiling Algorithm (ASPA): setting the stage for Next-Generation Risk Assessment	9
P17-04 Unveiling the Hidden Threat: Genotoxicity and Oxidative Stress Induced by Microplastics in Human Health and Immune Disorders	8
P17-21 Effects of early-life BPA analog exposure on natural killer cell function and development	8
Editorial Board	8
Spilled liquid mercury: Case studies, proposition of safety procedures with assessment of commercial cleanup kit and recommendations	8
S05-03 Shear forces affect cell differentiation and cell sensitivity in organs-on-chip models	8
CEC01-03 The current biological understanding of the respiratory tract, the in vitro models available as well as their use	8
S16-03 Microbial pesticides: a regulatory overview	8
S17-02 OASIS Consortium: Strategies for detecting in vivohepatotoxicity with in vitro‘omic technologies	8
P03-01 Harnessing the power of AI to drive organ-level toxicity predictions	8
S12-06 Finding European research funding and writing a competitive research proposal	8

P13-03 Comparative study of mutagenic/antimutagenic and genotoxic/antigenotoxic activities of ethanolic and aqueous extracts prepared from Arbutus unedo fruits	8
P17-13 Optimization of Macrophage Polarization and Phagocytosis Assays for Immunotoxicology Studies	8
P21-12 Investigating the hematotoxic effects of the mixture of lead and polychlorinated-biphenyls by combining in vivo and in silico approach	8
P23-12 Updating Finnish biomonitoring reference values and health-based guidance values for occupational exposure and risk assessment of selected metals	8
P31-18 Protective Effects of N-Acetylcysteine and Coenzyme Q10 Against Atorvastatin-Induced Myopathy and Oxidative Damage	8
P24-15 Targeted groundwater monitoring for plant protection products and their metabolites in agricultural regions of Slovenia	8
P18-62 Mechanistic Insights of BPA Alternatives on PPARγ Binding and Consequences on Adipocyte Differentiation	8
P19-26 Assessment of hepatotoxicity induced by heat-not-burn cigarette extract using various types of hepatocytes	8
Harmful beauty – Temporal profile of urinary phthalate metabolites in tattooed volunteers from Slovakia	8
P01-63 The secretion of interleukin 18 by reconstructed human epidermis is a biomarker for in vitro prediction of skin photosensitization	8
P18-64 Ring trial validation of a cell-based RAR transactivation method	8
LP-22 In vitro Metabolite Profiling of CF3-Etomidate: A New Etomidate Analogs	8
P22-46 Effects of plastic nanoparticles, paracetamol, ibuprofen and their mixtures on steroidogenesis in vitro	8
P20-14 The effect of non-functionalized polystyrene nanoparticles with varying diameters on human albumin (in vitro)	8
P30-59 Interest of the Micronucleus test on Reconstructed Skin and skin organoids for cosmetic products	7
CEC06-03: Documenting pesticide exposures from field studies: what is known and why we should know more	7
P22-02 Cytotoxic and genotoxic effects induced by aluminium oxide nanoparticles on TM3 Leydig cells	7
P23-03: Applying the Multiple Path Particle Dosimetry model for assessing Occupational Exposure to Active Pharmaceutical Ingredients	7
P26-11: Acute and subacute toxicity profiles in Sprague-Dawley (SD) rats treated with Piperis Longi Fructus (PLF) Powder	7
P17-09: Polystyrene microplastics of varying sizes and shapes induce distinct redox and mitochondrial stress responses in a Caco-2 monolayer	7
P10-25: Cytotoxic and genotoxic effects of particulate matter emitted in beauty salons	7
S13-01: How far are we with the implementation of NGRA for cosmetics?	7
P28-22 Identification of candidate molecular markers for detection of abnormal Mullerian duct morphology in male Japanese quail embryos exposed to estrogenic substances	7
Editorial Board	7
P14-36 Development and optimization of flow cytometry driven analysis of micronucleus in vitro using 3D skin tissues	7
P10-03: Cadmium levels are related to clonal hematopoiesis and mortality	7
P06-40: Integrating physiologically-based pharmacokinetic modelling and 'omics data to derive a health-based guidance value for perfluorooctanoic acid	7
CEC01-01: A hands-on introduction to applied artificial intelligence in toxicology	7
P22-11: Case study of resveratrol as a cosmetic ingredient for systemic toxicity using the new approachmethodologies of next generation risk assessment	7
P01-04: Development of an Adverse Outcome Pathway (AOP) to assess the neurotoxicity of the exposure to benzo(a)pyrene	7
P16-21: Applications of an isogenic human iPSC-derived blood-brain barrier (BBB) model	7
Do urinary metabolites reflect occupational exposure to organophosphate flame retardants? A case study in electronic waste recycling workers.	7
P33-05 Preliminary Toxicological Evaluation of Four Candidate Radiosensitizers in Sprague-Dawley Rats	7
P11-02: Online methods and tools for assessing chemical exposure in humans: a systematic scoping review for the ONTOX project	7
P18-78 What does new nitrosamine data reveal about the CPCA framework?	7
P08-15 Evaluation of nanoatrazine bioaccumulation in green microalga Raphidocelis subcapitata: characterization, stability and uptake analysis	7
P01-02: An updated adverse outcome pathway network on chemical-induced liver steatosis	7
P22-08: New strategies for the safety assessment of proteins in food/feed derived from biotechnology – the way forward	7
P04-06: Toxicity of particulate matter from experimental burning of domestic waste	7
P25-05: Media representation of Glyphosate in Slovenian Printed Media over 10 year period	7
BDE-47 induces metabolic dysfunction-associated steatotic liver disease (MASLD) through CD36-mediated increased fatty acid uptake and PPARα-induced abnormal fatty acid oxidation in BALB/c mice	7
P17-30: Amorphous silica nanomaterials effects on human dendritic cells promote the T-cell response to the pneumallergen Bet v 1a	6
P12-08 Biological evaluation of pharmaceuticals inhibiting 11β-hydroxylase identified by virtual screening	6
P12-59 Assessing the placental transfer of dexamethasone via ex vivo human placenta perfusions: a step-up towards model informeddrug dosing in pregnancy	6
Analysis of structure phototoxicity relationship towards the de-risking of phototoxic liabilities in early drug discovery	6
Binding of ligands to the aryl hydrocarbon receptor: An overview of methods	6
Toxicity prediction using target, interactome, and pathway profiles as descriptors	6
S-05-02 How can grouping and read-across support safe(r)-by-design of nanomaterials and advanced materials? GRACIOUS	6
P22-05 Identification and hazard assessment of oligoesters, nonintentionally added substances present in food contact coating extracts	6
P04-16 In silico applications for the prediction and hazard assessment of transformation products originated from water disinfection treatment processes	6
P17-12 Molecular network pathway analysis of arsenic and cisplatin in cancer	6
LP-23 Molecular glue degrader reproductive toxicity: what did we learn?	6
P21-16 Cytotoxicity: regulatory definitions versus scientific knowledge	6
P22-27 Exposure assessment of total DON in urine of Portuguese adult population under the HBM4EU aligned studies	6
LP-04: Adverse Outcome Pathways of Toxicity-Induced Dry Eye: implication of ferroptosis and pyroptosis in corneal neuroepithelial entity	6
P08-12 The surfactant co-formulant POEA in the glyphosate-based herbicide RangerPro but not glyphosate alone causes necrosis and ER stress in mammalian cell lines	6
The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of Black Snake (Pseudechis spp.) venoms	6
LP-37 Biokinetics of fluorophore-conjugated microplastics in marine mussels	6
PPARγ activation inhibits endocytosis of claudin-4 and protects against deoxynivalenol-induced intestinal barrier dysfunction in IPEC-J2 cells and weaned piglets	6
Toxicokinetic analysis of the highly toxic nerve agent VX in commercially available multi-organ-chips – Ways to overcome compound absorption	6
LP-20 Halogen-free flame retardant is friendlier to the aquatic environment than PBDEs	6
P12-32 An all-human cell based tri-culture system distinguished through morphology, longevity, and functionality	6
P11-26 Exosomes derived from primed mesenchymal stem cells improve cell viability on an APAP-induced hepatic injury in vitro model	6
S-31-01 Setting the scene: human health impacts of micro- and nanoplastics (MNPs)	6
Corrigendum to “Furocoumarins affect hepatic cytochrome P450 and renal organic ion transporters in mice” [Toxicol. Lett. 209 (2012) 67–77]	6
P03-22: Sensitivity of primary human hepatocytes and HepG2 cells for genotoxicity testing of N-nitrosamines in the in vitro alkaline comet assay	6
miR-520f-3p blocks MNNG-induced gastric precancerous lesions via the KLF7/NFκB pathway	6
P22-03: Read-Across case study – from hypothesis to regulatory acceptance	6
P16-17 The senescence-associated secretory phenotype (SASP) from colorectal cancer cells induce neurotoxicity: novel mechanism involvement of CD38-NAD+ pathways	6
Corrigendum to “The ameliorative effect of niclosamide on bile duct ligation induced liver fibrosis via suppression of NOTCH and Wnt pathways” [Toxicol. Lett. 347 (2021) 23–35]	6
Adefovir accumulation in the renal interstitium triggers mast cell degranulation and promotes renal interstitial fibrosis	6
In vitro/in silico prediction of drug induced steatosis in relation to oral doses and blood concentrations by the Nile Red assay	6
The suitability of a polydimethylsiloxane-based (PDMS) microfluidic two compartment system for the toxicokinetic analysis of organophosphorus compounds	6
KL06 | Keynote Lecture	6
P10-12 Investigation of the effects of endocrine disruptors on T cells differentiation	6
S-26-01 Methylmercury-induced modification of selenocysteine in selenoprotein P – Implication to its physiological function	6
P22-11 Current challenges in water quality require advanced risk assessment	6
P11-05 Toxic microelements levels in the blood clot of wild boar (Sus scrofa) for monitoring the contamination and biomarkers changes	6
P03-04 Validation of an analytical method to identify and quantify selected amphetamine-related drugs (ARDs) in whole blood (WB) using UPLC-qTOF-MS after extraction by MMSPE	6
Corrigendum to “Inducible factors and interaction of pulmonary fibrosis induced by prenatal dexamethasone exposure in offspring rats” [Toxicol. Lett. 359 (2022) 65–72]	5
P09-26: Methods for the assessment of deiodinases inhibition by thyroid hormone disrupting chemicals and environmental pollutant mixtures	5
CEC05-04: The systemic effects of nano-size particles: lessons from the cardiovascular system	5
S21-02: The Halifax Project 10 years later: what we've learned and what we are still missing on the cumulative carcinogenic effect of environmental chemicals	5
S22-02: In vitro assessment of immunotoxicity with a focus on immunosuppression	5
OS02-05: Genotoxicity in peripheral blood leukocytes and reticulocytes of e-waste management workers	5
P24-31: The Human Health dataset of the approved biocidal active substances	5
P24-06: Applicability of the DPRA on mixture testing: Challenges and opportunities	5
P09-19: Evaluation of new alternative methods to endocrine disruption: a comparison of in vitro and in silico results	5
P08-05: 3D microphysiological placenta in-vitro model as a tool for drug transport studies and risk assessment	5
P03-21: Genotoxicity and mutagenicity assessment of sediment samples from the Stolberg area in Western Germany following the extreme flood event in 2021	5
LP-25: The curious case of Adverse Outcome Pathways: the stressor agnostic approach bridging disciplines by embracing evidence from diverse initiating factors	5
P02-08: Active cigarette smoking affects trace element levels and sex steroids in the maternal-placental-fetal unit	5
CEC01-04: Toxicogenomics data and analysis workflows	5
TP induces hepatic intolerance to FasL-mediated hepatocyte apoptosis by inhibiting XIAP	5
P23-09: Filling in safety data sheets for data-poor substances relevant to drug development	5